22.90USD+1.94%Mkt Cap: 1.69B USDP/E: 3.66Last update: 2026-05-26
Innoviva, Inc. operates as a biopharmaceutical company in the United States and internationally. Its royalty portfolio includes RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol, and…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
105.81BDKKP/E 20.4
66.47BUSDP/E 15.5
46.56BEURP/E 30.5
43.89BEURP/E 36.5
39.41BUSDP/E 74.0
32.84BUSD—
32.05BSEKP/E 47.4
Indicators:|
Key Statistics
Company
Market Cap1.69B USD
Enterprise Value1.36B USD
Revenue (TTM)420.69M USD
Gross Profit333.94M USD
Net Income (TTM)271.17M USD
Revenue/Share5.988 USD
Last Price22.90 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees159
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS45781M1018
Valuation
P/E (Trailing)3.66
P/E (Forward)10.05
PEG0.32
EV/EBITDA7.05
EV/Revenue3.23
P/S3.89
P/B1.22
EPS (TTM)6.26
EPS (Forward)2.21
52W Range
16.5274% of range25.15
52W High25.15 USD
52W Low16.52 USD
Profitability
Gross Margin81.19%
Oper. Margin40.11%
EBITDA Margin45.81%
Profit Margin65.92%
ROE23.12%
ROA16.58%
Growth
Revenue Growth10.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF196.93M USD
CapEx (TTM)10.50M USD
FCF Margin25.00%
FCF Yield6.22%
Net Debt-280.51M USD
Net Debt/EBITDA-1.46
Balance Sheet
Debt/Equity0.23
Current Ratio21.13
Quick Ratio19.27
Book Value/Sh18.18 USD
Cash/Share8.291 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateSep 8, 2015
Pay DateSep 30, 2015
Splits
Last Split1241:1000
Split DateJun 3, 2014
Analyst Consensus
Rating2.0 (Buy)
Target (Mean)35.50 USD
Target Range18.00 USD – 46.00 USD
# Analysts4
Ownership
Shares Out.73.81M
Float69.07M
Insiders0.99%
Institutions107.95%
Short Interest
Short Ratio9.7d
Short % Float11.47%
Short % Out.8.51%
Shares Short6.28M
Short (prev mo.)6.55M
Technical
SMA 5022.91 (-0.1%)
SMA 20020.84 (+9.9%)
Beta0.38
S&P 52W Chg28.31%
Avg Vol (30d)663.64K
Avg Vol (10d)774.54K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—